Journal of Clinical Endocrinology & Metabolism, Vol 58, 895-903, Copyright © 1984 by Endocrine Society

ARTICLES

Effects of chronic beta-receptor stimulation on sympathetic nervous system activity, energy expenditure, and thyroid hormones

K Scheidegger, M O'Connell, DC Robbins and E Danforth Jr

The effects of hyper- and hypothyroidism on sympathetic nervous system activity and energy expenditure are well recognized. The impact of altered sympathetic nervous system activity on energy expenditure and thyroid hormone metabolism has not been well studied. We investigated the effects of orally administered terbutaline sulfate, a beta 2- receptor agonist (5 mg, three times per day for 2 weeks), on the activity of the sympathetic nervous system, energy expenditure, and thyroid hormone metabolism in six normal men, aged 21-36 yr. The cardiovascular, metabolic, and thermogenic responses to an infusion of the beta-adrenergic agonist isoproterenol were clearly blunted after 2 weeks of treatment with terbutaline sulfate, indicating down-regulation of beta-receptors and/or development of reduced sensitivity. There were no significant changes in the cardiovascular, metabolic, or thermogenic responses to an infusion of the alpha-adrenergic agonist phenylephrine. Basal metabolic rate was significantly increased by the chronic administration of terbutaline sulfate [5.040 +/- 0.167 (+/- SE) vs. 5.421 +/- 0.234 kJ/min; P less than 0.05]. There was a highly significant change in the serum T3 to T4 ratio (19.4 +/- 1.0 vs. 24.4 +/- 1.0; P less than 0.001). This was a result of increased serum T3 concentrations (136 +/- 9 vs. 160 +/- 14 ng/dl; P less than 0.05) and decreased serum T4 concentrations (7.2 +/- 0.8 vs. 6.7 +/- 0.8 micrograms/dl; P = NS). Chronic beta-receptor stimulation with terbutaline sulfate increases the basal metabolic rate and T3 concentrations. These changes occurred despite down-regulation of beta- receptors and/or decreased sensitivity in response to chronic terbutaline administration.

This article has been cited by other articles:

				W. S. da-Silva, J. W. Harney, B. W. Kim, J. Li, S. D.C. Bianco, A. Crescenzi, M. A. Christoffolete, S. A. Huang, and A. C. Bianco The Small Polyphenolic Molecule Kaempferol Increases Cellular Energy Expenditure and Thyroid Hormone Activation Diabetes, March 1, 2007; 56(3): 767 - 776. [Abstract] [Full Text] [PDF]

				L. H. Canani, C. Capp, J. M. Dora, E. L. S. Meyer, M. S. Wagner, J. W. Harney, P. R. Larsen, J. L. Gross, A. C. Bianco, and A. L. Maia The Type 2 Deiodinase A/G (Thr92Ala) Polymorphism Is Associated with Decreased Enzyme Velocity and Increased Insulin Resistance in Patients with Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3472 - 3478. [Abstract] [Full Text] [PDF]

				S. L. H. Schiffelers, E. E. Blaak, E. M. Baarends, M. A. Van Baak, W. H. M. Saris, E. F. M. Wouters, and A. M. W. J. Schols {beta}-Adrenoceptor-mediated thermogenesis and lipolysis in patients with chronic obstructive pulmonary disease Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E357 - E364. [Abstract] [Full Text] [PDF]

				K. Collomp, R. Candau, F. Lasne, Z. Labsy, C. Prefaut, and J. De Ceaurriz Effects of short-term oral salbutamol administration on exercise endurance and metabolism J Appl Physiol, August 1, 2000; 89(2): 430 - 436. [Abstract] [Full Text] [PDF]

				G. A. Bray and F. L. Greenway Current and Potential Drugs for Treatment of Obesity Endocr. Rev., December 1, 1999; 20(6): 805 - 875. [Abstract] [Full Text]